Life Science Investing Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon's Presence at the Association for Vascular Access 2025 Annual Meeting 9h
Life Science Investing Covalon Technologies Ltd. Achieves DTC Eligibility in the United States 20 August
Life Science Investing CORRECTING and REPLACING Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2025 Financial Results 14 August
